Aurora Cannabis Inc. (TSX:ACB)
| Market Cap | 270.21M -25.2% |
| Revenue (ttm) | 373.12M +16.5% |
| Net Income | -83.99M |
| EPS | -1.50 |
| Shares Out | 59.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 309,967 |
| Average Volume | 551,314 |
| Open | 4.590 |
| Previous Close | 4.600 |
| Day's Range | 4.480 - 4.590 |
| 52-Week Range | 4.285 - 9.330 |
| Beta | 1.33 |
| RSI | 44.72 |
| Earnings Date | Jun 17, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
NASDAQ | TSX: ACB Canadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding program EDMONTON, AB, May 14, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NA...
Top Canadian Cannabis Penny Stocks to Watch This Month
The cannabis sector continues to attract investors seeking growth opportunities in 2026. Marijuana penny stocks remain volatile. However, they also offer strong upside potential when market momentum i...
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
NASDAQ | TSX: ACB Q1 launches reinforce Aurora's medical‑first strategy, expanding access to high‑quality products across multiple formats Scaled launches across Canada, Europe and Australia support g...
'GIANT STEP FORWARD': Reclassification of medical cannabis lauded
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.' 00:00 Introduction & Re...
'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana
The Trump administration reclassified medical marijuana as a less dangerous drug on Thursday. FDA-approved and state-licensed medical marijuana was rescheduled from a Schedule I drug to the less stric...
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling Food and Drug Administration-approved and state-licensed medical cannabis products as a...
Aurora Cannabis (ACB) Benefits from Rescheduling of Cannabis Products
Aurora Cannabis (ACB) Benefits from Rescheduling of Cannabis Products
Aurora Cannabis (ACB) Sees Regulatory Shift Towards Medical Marijuana Research
Aurora Cannabis (ACB) Sees Regulatory Shift Towards Medical Marijuana Research
Cannabis rescheduling fuels optimism across industry
The U.S. Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as less dangerous in one of the biggest changes t...
Why are cannabis stocks surging today?
Shares of major cannabis companies rallied sharply on Wednesday after reports suggested the Trump Administration could soon move to reclassify marijuana, a long-awaited step that investors believe cou...
Aurora Cannabis (ACB) Set to Benefit from Potential Reclassification of Cannabis
Aurora Cannabis (ACB) Set to Benefit from Potential Reclassification of Cannabis
Canadian cannabis producer targets international markets in $26.5M deal
Aurora Cannabis Inc. has bought Safari Flower Co. in a stock-and-cash deal valued at $26.5 million.
Canada’s Aurora Cannabis (ACB) Looks Overseas As Domestic Market Goes Up in Smoke
The black market continues to impact producers.
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
NASDAQ | TSX: ACB EDMONTON, AB, April 15, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is ...
3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026
The Canadian cannabis sector continues to evolve in 2026, even as volatility remains elevated. Total Canadian cannabis sales have steadily increased in recent years, showing consistent demand growth. ...
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
NASDAQ | TSX: ACB The Globe and Mail's Report on Business Women Lead Here List acknowledges Aurora's commitment to inclusive leadership at the executive level EDMONTON, AB, March 30, 2026 /PRNewswire/...
Top Canadian Marijuana Stocks To Watch This Month For Better Trading
The cannabis industry has made a tremendous impact on the world. From being once a taboo subject to now a well-respected and much more accepted industry. Even the thought of what may happen to a legal...
New Bill Could Impact Cannabis Stocks Like Aurora Cannabis (ACB)
New Bill Could Impact Cannabis Stocks Like Aurora Cannabis (ACB)
Aurora Cannabis Inc at TD Cowen Healthcare Conference Transcript
Aurora Cannabis Inc at TD Cowen Healthcare Conference Transcript
Aurora Cannabis Transcript: TD Cowen 46th Annual Health Care Conference
The company has completed a major restructuring, focusing on high-margin medical cannabis and divesting lower-margin segments. Strong growth is driven by international markets, especially Europe and Australia, supported by operational excellence, regulatory expertise, and a robust balance sheet.
3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio
Marijuana stocks, even with their volatile behavior, still offer diverse investment opportunities. Not every sector or company deals directly with the plant, so investors see this as an opportunity to...
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?
Aurora Cannabis has had a terrible track record in recent years. Even if recent regulatory changes in the U.S. cause a new pot boom, Aurora is unlikely to capitalize on it.
Aurora Cannabis (ACB) Sees Notable Increase in Indicative Borrow Rate
Aurora Cannabis (ACB) Sees Notable Increase in Indicative Borrow Rate
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference
NASDAQ | TSX: ACB Canada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market Opportunities EDMONTON, AB, Feb. 17, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASD...
